Analyst firms · Wolfe Research · RPD
Wolfe Research RPD price target and rating history
Rapid7 Inc. (RPD) · Technology
Wolfe Research rates Rapid7 Inc. (RPD) Outperform with a $56 price target, as of its latest action on Nov 3, 2023. It has published 3 rating actions on RPD since April 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a RPD price target in the last 12 months, the median target is $12.50.
- Current rating
- Outperform
- Price target
- $56
- Median target, all firms
- $12.50
- Actions on RPD
- 3
Wolfe Research price target on RPD
Every Wolfe Research rating on RPD
- Nov 3, 2023
- Nov 4, 2022
- Apr 11, 2022
How other firms rate RPD
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Morgan Stanley | Underweight | $9 | Jul 21, 2026 |
| William Blair | Mkt Perform | Apr 29, 2026 | |
| UBS | Neutral | $9 | Feb 11, 2026 |
| Canaccord Genuity | Hold | $10 | Feb 11, 2026 |
| Citigroup | Neutral | $15 | Jan 13, 2026 |
| Barclays | Underweight | $15 | Jan 5, 2026 |
| Berenberg | Hold | $16 | Nov 18, 2025 |
Questions about Wolfe Research and RPD
- What is Wolfe Research's price target for RPD?
- Wolfe Research's latest stated price target for Rapid7 Inc. (RPD) is $56, from its action on Nov 3, 2023.
- What is Wolfe Research's rating on RPD?
- Wolfe Research rates RPD Outperform, a bullish rating, as of Nov 3, 2023.
- When did Wolfe Research last change its view on RPD?
- On Nov 3, 2023, Wolfe Research upgrades to Outperform from Peer Perform, price target $56.
- How does Wolfe Research's RPD target compare with other analysts?
- Across 6 firms with a RPD price target in the last 12 months, the median target is $12.50.
More RPD rating histories
- Morgan Stanley5
- UBS3
- Canaccord Genuity4
- Citigroup3
- Barclays4
- RBC Capital Markets5
- KeyBanc Capital Markets5
- Mizuho4
- Needham4
All Wolfe Research ratingsRPD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.